Studies are displaying evidence that new strains of cannabis can aid the battle against opioid addiction and in turn, create yet another new revenue opportunity in the burgeoning and vast cannabis landscape. As America fights an alarmingly disturbing opioid epidemic, the results of these studies could push legislators to continue paving the way for legal use of medical strains of cannabis throughout the country. Researchers studied patients using prescription opioids to treat chronic pain who enrolled in a recent program between 2010 and 2015 discovered patients using cannabis based therapies reported pain reduction, quality of life, social life, activity levels, and concentration, and few side effects from using cannabis one year after enrollment in the New Mexico study program. Active in the legal cannabis markets today include: Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF), Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF), Aphria Inc. (TSX: APH) (OTC: APHQF), Aurora Cannabis